<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03996447</url>
  </required_header>
  <id_info>
    <org_study_id>GDX-44-010</org_study_id>
    <nct_id>NCT03996447</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)</brief_title>
  <acronym>PICTURE</acronym>
  <official_title>Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guerbet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guerbet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the trial aims to evaluate the Efficacy and Safety of gadopiclenol for Central Nervous System
      (CNS) Magnetic Resonance Imaging (MRI)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this trial is to evaluate a new gadolinium-based contrast agent (GBCA)
      gadopiclenol injection for Central Nervous System (CNS) lesion detection and visualization by
      conventional steady-state CNS imaging. .

      This is a multi-center, international, prospective, double-blind, randomized,
      controlled,cross-over with comparator trial in male and female patients presenting with known
      or highly suspected CNS lesion(s) with focal areas of disrupted Blood Brain Barrier (BBB)
      (e.g., primary and secondary tumors) who are scheduled to undergo a routine contrast-enhanced
      Magnetic Resonance Imaging (MRI) of the CNS.

      This trial will be conducted in approximately 40 centers worldwide.

      During the course of the trial, two MRIs will be obtained from each patient: one unenhanced
      and gadopiclenol-enhanced MRI; and one unenhanced and gadobutrol-enhanced MRI. MRI
      evaluations will be performed by on-site investigators and three independent off-site blinded
      readers.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 3, 2019</start_date>
  <completion_date type="Anticipated">October 2, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 15, 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>lesion visualization criteria for gadopiclenol-enhanced MRI compared to unenhanced MRI</measure>
    <time_frame>1 day procedure</time_frame>
    <description>The lesion visualization criteria is based on 3 co-primary criteria: border delineation, internal morphology and degree of contrast enhancement, assessed on the images acquired during the MRI performed with gadopiclenol by independent readers for the 3 most representative lesions.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lesion visualization criteria for gadopiclenol compared to gadobutrol</measure>
    <time_frame>1 day procedure</time_frame>
    <description>the lesion visualization criteria is based on 3 co-primary criteria: border delineation, internal morphology and degree of contrast enhancement assessed on the images acquired during the MRI performed with gadopiclenol and those performed with gadobutrol.
For each reader, only matching lesion between paired images of gadobutrol and gadopiclenol will be considered</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>CNS Lesion</condition>
  <condition>Blood Brain Barrier Defect</condition>
  <arm_group>
    <arm_group_label>gadopiclenol-enhanced MRI then gadobutrol-enhanced MRI</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>cross-over design. each patient will receive gadopiclenol for the first MRI and gadobutrol for the second MRI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>gadobutrol-enhanced MRI then gadopiclenol-enhanced MRI</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>cross-over design. each patient will receive gadobutrol for the first MRI and gadopiclenol for the second MRI</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>gadopiclenol</intervention_name>
    <description>single intravenous (IV) bolus injection at a rate of 2ml/second</description>
    <arm_group_label>gadobutrol-enhanced MRI then gadopiclenol-enhanced MRI</arm_group_label>
    <arm_group_label>gadopiclenol-enhanced MRI then gadobutrol-enhanced MRI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gadobutrol 1Mmol/mL Solution for Injection Vial</intervention_name>
    <description>single intravenous (IV) bolus injection at a rate of 2ml/second</description>
    <arm_group_label>gadobutrol-enhanced MRI then gadopiclenol-enhanced MRI</arm_group_label>
    <arm_group_label>gadopiclenol-enhanced MRI then gadobutrol-enhanced MRI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient presenting with known or highly suspected CNS lesion(s) with focal areas of
             disrupted Blood Brain Barrier (BBB) (e.g., primary and secondary tumors) based on
             results of a previous imaging procedure such as Computed Tomography (CT) or MRI, which
             should have been performed within 12 months prior to ICF signature.

        Exclusion Criteria:

          -  Patient presenting with acute or chronic renal insufficiency, defined as an estimated
             Glomerular Filtration Rate (eGFR) &lt; 30 mL/min/1.73 m² assessed within 1 day prior to
             each contrast agent injection

          -  Patient presenting extra cranial lesions and/or extra-dural lesions.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lorie Loevner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Corinne Dubourdieu</last_name>
    <phone>+33145915000</phone>
    <email>corinne.dubourdieu@guerbet.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>ASCLEPES Research Centers</name>
      <address>
        <city>Panorama City</city>
        <state>California</state>
        <zip>91402</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anil Sharma, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Connecticut Health Center</name>
      <address>
        <city>Farmington</city>
        <state>Connecticut</state>
        <zip>06030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abner Gershon, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>George Washington University Medical Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mohammad Taheri, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwestern Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Liu, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwest Neurology, Ltd.</name>
      <address>
        <city>Rolling Meadows</city>
        <state>Illinois</state>
        <zip>600008</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Gordon, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Leo Tsaï, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Missouri Hospital and Clinic</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ayman Gaballah, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ohio State University Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eric Bourekas, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurie Loevner, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>South Carolina Clinical &amp; Translational Research (SCTR) Institute</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donna Roberts, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Of Washington - Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Fink, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>ZNA Middelheim</name>
      <address>
        <city>Antwerp</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Didier De Surgeloose, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>UZ Brussel - Campus Jette</name>
      <address>
        <city>Brussel</city>
        <zip>1090</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johan de Mey, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU - Hôpital Roger Salengro - Neurologie</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Pierre Pruvo, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Sainte-Anne</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Oppenheim, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU La Miletrie</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rémy Guillevin</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU Strasbourg Hôpital de Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stéphane Kremer, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Semmelweis Egyetem - Neurology</name>
      <address>
        <city>Budapest</city>
        <zip>1083</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dániel Bereczki, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Orszagos Klinikai Idegtudomanyi Intezet</name>
      <address>
        <city>Budapest</city>
        <zip>1145</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Attila Bago, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Debreceni Egyetem Klinikai Kozpont</name>
      <address>
        <city>Debrecen</city>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabor Hutoczki, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pecsi Tudomanyegyetem Klinikai Kozpont - Idegsebeszeti Klinika</name>
      <address>
        <city>Pécs</city>
        <zip>Pécs</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andras Buki, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Szegedi Tudomanyegyetem AOK</name>
      <address>
        <city>Szeged</city>
        <zip>6725</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pal Barzo, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>ASL 1 Abruzzo Avezzano-Sulmona-L'Aquila, Ospedale Regionale San Salvatore</name>
      <address>
        <city>L'Aquila</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandra Splendiani, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fondazione I.R.C.C.S. C.Mondino</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Pichiecchio, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Istituto Neurologico Mediterraneo-Neuromed, I.R.C.C.S.</name>
      <address>
        <city>Pozzilli</city>
        <zip>86077</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marcello Bartolo, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Azienda Sanitaria Universitaria Integrata di Trieste-PO Cattinara</name>
      <address>
        <city>Trieste</city>
        <zip>34149</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Cova, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Konkuk University Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>05030</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Won Jin Moon, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Catholic University of Korea Seoul St.Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>06591</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>5505</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ho Sung Kim, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Axis Heilsa S. de R.L. de C.V. (Althian)</name>
      <address>
        <city>Monterrey</city>
        <zip>64060</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>José Alfonso Meza Medina, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Research Institute S.C</name>
      <address>
        <city>Tlalnepantla de Baz</city>
        <zip>54055</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel San Juan, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Uniwersyteckie Centrum Kliniczne w Gdańsku, Zakład Radiologii</name>
      <address>
        <city>Gdańsk</city>
        <zip>80-214</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katarzyna Dziadziuszko, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Krakowski Szpital Specjalistyczny im. Jana Pawła II , Zakład Radiologii i Diagnostyki Obrazowej</name>
      <address>
        <city>Kraków</city>
        <zip>31-202</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Malgorzata Urbanczyk-Zawadzka, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital del Mar</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaume Capellades, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>M.D. Anderson Cancer Center Madrid</name>
      <address>
        <city>Madrid</city>
        <zip>28033</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Lourido García, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico San Carlos</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Arrazola, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>10002</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Taipei Veterans General Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>11217</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Korea, Republic of</country>
    <country>Mexico</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>Taiwan</country>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>June 21, 2019</study_first_submitted>
  <study_first_submitted_qc>June 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 24, 2019</study_first_posted>
  <last_update_submitted>June 3, 2020</last_update_submitted>
  <last_update_submitted_qc>June 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

